Pallas Capital Advisors LLC Buys New Shares in Agilent Technologies, Inc. $A

by · The Markets Daily

Pallas Capital Advisors LLC bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 16,808 shares of the medical research company’s stock, valued at approximately $1,984,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Gateway Investment Advisers LLC grew its holdings in shares of Agilent Technologies by 157.9% during the 2nd quarter. Gateway Investment Advisers LLC now owns 167,191 shares of the medical research company’s stock valued at $19,730,000 after purchasing an additional 102,362 shares during the last quarter. Aaron Wealth Advisors LLC bought a new position in shares of Agilent Technologies during the 2nd quarter valued at $270,000. Financiere des Professionnels Fonds d investissement inc. grew its holdings in shares of Agilent Technologies by 19.5% during the 2nd quarter. Financiere des Professionnels Fonds d investissement inc. now owns 100,301 shares of the medical research company’s stock valued at $11,837,000 after purchasing an additional 16,346 shares during the last quarter. Dudley & Shanley Inc. grew its holdings in shares of Agilent Technologies by 12.2% during the 2nd quarter. Dudley & Shanley Inc. now owns 55,200 shares of the medical research company’s stock valued at $6,514,000 after purchasing an additional 6,000 shares during the last quarter. Finally, Czech National Bank grew its holdings in shares of Agilent Technologies by 6.4% during the 2nd quarter. Czech National Bank now owns 69,689 shares of the medical research company’s stock valued at $8,224,000 after purchasing an additional 4,163 shares during the last quarter.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the firm’s stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on A shares. Evercore ISI cut their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating on the stock in a report on Thursday, August 28th. TD Cowen raised their price target on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a report on Thursday, May 29th. Wall Street Zen lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Robert W. Baird raised their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. Finally, UBS Group cut their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a report on Thursday, May 29th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $140.08.

View Our Latest Report on A

Agilent Technologies Trading Down 0.2%

NYSE:A opened at $126.91 on Thursday. The company has a 50-day moving average price of $120.12 and a 200-day moving average price of $115.93. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market cap of $35.98 billion, a price-to-earnings ratio of 29.79, a P/E/G ratio of 3.96 and a beta of 1.24.

Agilent Technologies (NYSE:A – Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the company posted $1.32 EPS. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is 23.24%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).